Creatine + Beta‑Alanine: Haɗin da Ba Su Ba da Fa’ida

An gabatar da shi a kasuwa – menene hakikanin sakamakon?

Kun taɓa ganin buhunan pre‑workout da ake kira “ultimate performance stack”. A cikin su ana sayar da creatine da beta‑alanine a matsayin kunshin guda da zai ƙara wa juna ƙarfi. Sai wani sabon systematic review da network meta‑analysis da aka wallafa a Journal of the International Society of Sports Nutrition ya bincika wannan tunani, ya kuma gano cewa creatine ne ke haifar da tasiri, yayin da haɗin ba ya ƙara wani abu da auna.

Menene masu binciken suka yi a zahiri?

Bai da Xu da ƙungiyarsa daga Jiangxi University of Science and Technology (China) sun bi ka’idojin PRISMA. Sun yi tanadi a PubMed, Scopus da Web of Science har zuwa watan Agusta 2025. Sun tara gwaje‑gwajen ƙarfafa da aka gudanar a yanayi na randomized controlled trials (RCT) na creatine, beta‑alanine, ko duka biyun tare, kuma waɗanda suka ɗauki akalla makonni biyu a jikin ‘yan wasa masu lafiya.

Gwaje‑gwajen 52 da suka samu PEDro score ≥ 6 sun cancanci shiga. Network meta‑analysis yana ba da damar kwatanta dabaru da dama a lokaci guda – a nan an haɗa creatine kaɗai, beta‑alanine kaɗai, haɗin su, da placebo. Abubuwan da aka auna sun haɗa da:

• Gudun sprint
• Tsallen vertical
• Agility (saurin motsi)
• Ƙarfin juriya na tsokar sama da ƙasa
• Maimaita‑sprint ability (RSA)

Babbar sakamako: creatine ya yi nasara, haɗin ba ta ƙara komai

Idan an kwatanta da placebo, creatine kaɗai ya haɓaka matuƙar ƙarfi:

• Gudu: SMD = ‑0.64 (p = 0.04) – alamar “‑” na nuni da saurin gudu.
• Tsalle: SMD = 0.33 (p = 0.002)
• Maimaita‑gudu: SMD = ‑0.78 (p = 0.01)
• Ƙarfin juriya na tsokar sama: SMD = 0.43 (p = 0.01)

Matsayin P na creatine a ƙididdiga na network meta‑analysis ya kai 0.90 ko sama a waɗannan fannoni, wato yana kan gaba ko kusa da shi a jerin zaɓuɓɓuka.

Beta‑alanine ta ba da "tasirin da ba shi da muhimmanci ko yanayi‑na‑musamman". Haɗin su biyu ba ya ba da fa’idar haɗin kai. Marubutan sun ƙare da cewa ƙara beta‑alanine ba ya ƙara wani ƙarin riba a kan creatine kaɗai.

Me ya sa “hanyoyi biyu” ba su yi aiki ba?

A takardar, an yi bayani kan yadda kowane sinadari ke aiki. Creatine yana taimakawa sake gina phosphocreatine da saurin juyin ATP – hakan ya ƙara ƙarfin haɓakar‑ƙarfi a gajeren lokaci. Beta‑alanine kuwa na ƙara carnosine a tsoka, wanda ke rage ƙururuwar acid a lokacin wahala.

Duk da cewa dabarun su daban‑daban, binciken bai ga wani haɗin tasiri ba. Marubutan sun nuna cewa buffering na beta‑alanine na iya zama takamaiman aikin da ba shi da ƙarfi isasshe da zai ƙara tasirin creatine. A ra’ayinsu, fa’idar creatine ta fi fitowa daga ingantaccen dawowar phosphocreatine da ƙarfafa neuromuscular, waɗanda suke da tasiri kai tsaye a gudu, tsalle da maimaita ƙoƙari.

Abubuwan da ba su motsa ba

Creatine ba ya haifar da canji mai muhimmanci a agility ko ƙarfin juriya na ƙasa (duka p > 0.05). Don haka ba zai magance dukkan nau’in aikin jiki ba, kuma ba a samu hujja da ke nuni da cewa zai inganta kowanne gwaji na performance ba.

Yaya sahihancin wannan shaida?

Makalun tana da ƙarfi. Ta ƙunshi kawai RCTs da aka gudanar a yanayi na random tare da PEDro score ≥ 6, kuma babu alamar publication bias ko rashin daidaito a matakin duniya baki ɗaya.

Sai dai, akwai wasu ƙuntatawa da za a lura da su:

• Heterogeneity: I² ya bambanta daga 0 % zuwa 73 %, wato wasu sakamako na iya fitowa daga gwaje‑gwajen da ba su da cikakken jituwa.
• Populasi: An takaita binciken ga manyan ‘yan wasa masu lafiya; ba lallai sakamakon ya shafi tsofaffi, masu cuta ko masu farawa ba.
• Jinsi da nau’in wasanni: An ba da shawarar a ƙara nazari kan bambance‑bambancen jinsi da wasanni, domin tasirin zai iya ɓoye a ƙungiyoyi daban‑daban.
• Tsawon lokaci da ƙirƙira: Ana buƙatar ƙarin RCTs masu tsawon lokaci, manyan ƙungiyoyi da kuma gwaje‑gwajen da ke duba hulɗar sinadiran.
• Beta‑alanine ba “babu amfani” ba ne: Binciken ya nuna ba ta da tasiri mai mahimmanci a cikin wannan nazari, amma ba yana nufin ba za a samu fa’ida a wasu yanayi ba.
• Ƙarancin bayani a takaitaccen rubutu: Takaitaccen rubutun ba ya ba da adadin fitowar ’yan wasa ko yawan mahalarta a kowanne rukuni, don haka a duba cikakken takarda kafin yanke hukunci.

Abubuwan da za a ɗauka a aikace

• Matsakaici da lokacin ɗauka: Takaitaccen rubutun ba ya fayyace adadin ko tsawon lokacin amfani. A ƙarin bincike da dama, ana ba da shawarar creatine monohydrate tsakanin gram 3‑5 a kullum, a sha akai‑akai, na akalla makonni biyu don a ga tasiri.
• Wa ya dace da shi: Bisa ga sakamakon, creatine ya fi dacewa ga ‘yan wasa da aikin su ya dogara da gudu, tsalle, maimaita ƙoƙarin ƙarfi ko ƙarfin juriya na tsokar sama – misali ‘yan wasan ƙungiya, masu tsere, da masu ɗaga nauyi.
• Wa zai guje wa haɗin: Idan burinku shi ne samun ƙarin fa’ida daga “stacking”, wannan binciken ba ya ba ku dalilin biyan kuɗi ga haɗin. Idan har yanzu kuna ɗaukar beta‑alanine kuma ba ku da wata matsala, ba wata hujja da ke nuna cewa yana da illa, amma ba ya ƙara tasirin creatine a cikin wannan nazari.
• Wa ya kamata ya yi taka tsantsan: Binciken ya ta’allaka ne akan manyan ‘yan wasa masu lafiya. Duk wanda ke da wata cuta – musamman masu matsalar koda, mata masu dauke da ciki, ko masu shan magani – ya kamata ya tuntuɓi likita kafin fara kowane ƙari.

Kammalawa

Idan kuna neman inda za ku zuba kuɗin ƙarin abincin ku, wannan network meta‑analysis na gwaje‑gwajen 52 RCT na goyi bayan creatine a matsayin ɗayan manyan ƙari masu ɗorewa ga aikin ƙarfi da anaerobic. Beta‑alanine na iya taimakawa a wasu yanayi, amma a wannan nazari ba ta ƙara creatine zuwa wani abu mafi girma ba. Gwaje‑gwajen da za su fi tsayi, manya‑manya da rukuni‑rukuni na iya ƙara haske a gaba, amma a yanzu, wannan haɗin ba shi da ƙima don biyan kuɗi na musamman.